Dr. Clark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-7772
Education & Training
- University of California (San Diego) Medical CenterResidency, Neurology, 1986 - 1990
- Legacy Health/Emanuel Medical CenterInternship, Internal Medicine, 1985 - 1986
- Oregon Health and Science University School of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1986 - Present
- WA State Medical License 2020 - 2027
- OR State Medical License 1990 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) Start of enrollment: 2000 Dec 01
- A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients Start of enrollment: 2000 Dec 01
- A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke Start of enrollment: 2002 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 96 citationsMatrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic StrokeJeffrey A. Switzer, David C. Hess, Adviye Ergul, Jennifer L. Waller, Livia S. Machado
Stroke. 2011-09-01 - 17 citationsRecognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation.Patricia Hartge, Elizabeth A. Holly, Allan C. Halpern, Richard W. Sagebiel, DuPont Guerry
Cancer Epidemiology, Biomarkers & Prevention. 1995-01-01 - 212 citationsSafety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.David C. Hess, Lawrence R. Wechsler, Wayne M. Clark, Sean I Savitz, Gary A. Ford
The Lancet. Neurology. 2017-05-01
Press Mentions
- Baby Boomers in RetirementMarch 11th, 2020
- Study: New Treatment Could Help Stroke PatientsApril 6th, 2017
- Pill to Prevent Strokes Also Prevents Diabetes, Study ShowsFebruary 18th, 2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: